openPR Logo
Press release

Pulmonary Valve Replacement Market Revenue to Reach USD 1.6 Billion by 2031, Driven by Technological Advancements and Rising Prevalence of Pulmonary Valve Disorders - Exclusive Report by Transparency Market Research, Inc.

03-28-2025 06:03 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pulmonary Valve Replacement Market

Pulmonary Valve Replacement Market

Pulmonary valve replacement, also known as lung valve replacement, is a surgical procedure aimed at replacing a damaged or diseased pulmonary valve. This critical heart valve regulates blood flow from the right ventricle to the pulmonary artery, ensuring that blood reaches the lungs for oxygenation.

The procedure is typically performed when conditions such as pulmonary valve stenosis, regurgitation, or other valve-related disorders impair proper cardiac function. In 2022, the global pulmonary valve replacement market was valued at US$ 1.0 billion, and with advances in surgical techniques-including minimally invasive and transcatheter approaches-the market is projected to reach over US$ 1.6 billion by 2031.

Unlock crucial data and key findings from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85497

Analysts' Viewpoint

Experts emphasize that the growth of the pulmonary valve replacement market is driven by a combination of clinical necessity and technological innovation. The rising prevalence of pulmonary valve disorders-attributed to improved survival rates of infants with congenital heart defects and lifestyle factors-coupled with advancements in surgical methods and implant materials, is significantly boosting market demand. Moreover, increased healthcare spending and heightened awareness regarding early detection and treatment of valve disorders further propel market expansion. Emerging economies are beginning to adopt these advanced procedures, offering substantial opportunities for market players to increase their revenue and share.

Market Drivers

Rise in Prevalence of Pulmonary Valve Disorders

Increased Diagnosis: Enhanced diagnostic techniques and greater awareness about congenital and acquired pulmonary valve disorders are contributing to higher detection rates.

Lifestyle & Environmental Factors: Sedentary behavior, poor diet, tobacco use, and environmental pollution are further increasing the prevalence of these conditions.

Technological Advancements in Cardiac Surgery

Minimally Invasive Procedures: Innovations such as transcatheter pulmonary valve replacement (TPVR) and robotic-assisted surgeries are reducing patient recovery times and procedural complications.

Advanced Implant Materials: Developments in biocompatible polymers and titanium alloys have led to more durable and long-lasting valve replacement devices.

Increased Healthcare Spending & Early Detection

Rising Investment: Higher healthcare budgets and improved patient access to advanced treatment facilities are driving market demand.

Preventive Care: Growing awareness of the benefits of early diagnosis and timely intervention in valve disorders is further supporting market expansion.

Uncover valuable insights by exploring our comprehensive report -

https://www.transparencymarketresearch.com/pulmonary-valve-replacement-market.html

Market Segmentation

Valve Type Segmentation

Mechanical Valve

High Durability: Mechanical valves, made from robust materials like metal and plastic, remain the dominant segment due to their long-term durability and reliability.

Biological, Donor, & Tissue Valves

Patient-Specific Considerations: These options provide alternative solutions based on patient age, health status, and lifestyle, offering flexibility in treatment approaches.

Application Segmentation

Pulmonary Valve Stenosis

Largest Segment: The high prevalence of pulmonary valve stenosis, a condition marked by the narrowing of the valve, drives the largest share of the market.

Pulmonary Atresia and Others

Emerging Opportunities: Although less common, other applications such as pulmonary atresia contribute to overall market growth through specialized treatment protocols.

End-user Segmentation

Hospitals

Preferred Settings: Hospitals continue to dominate the market as they offer the necessary infrastructure, advanced technology, and skilled personnel to perform complex valve replacement procedures.

Ambulatory Surgical Centers & Others

Supplementary Channels: These facilities also contribute significantly to market growth, particularly in regions with evolving healthcare systems.

Regional Outlook

North America
North America accounted for a major share of the global market in 2021, driven by a high incidence of heart valve diseases, robust healthcare infrastructure, and continuous investment in advanced surgical technologies.

Asia Pacific
The Asia Pacific region is the fastest growing market, propelled by an increasing incidence of pulmonary valve disorders, a surge in the geriatric population, and expanding healthcare infrastructure.

Other Regions
Latin America, Europe, and the Middle East & Africa also contribute to the market growth, supported by improving healthcare access and rising regulatory emphasis on cardiac care.

Competitive Landscape

The global pulmonary valve replacement market is highly fragmented with numerous international and local players. Key companies such as Boston Scientific, Edwards Lifesciences, Medtronic, St. Jude Medical, Abbott Laboratories, Cryolife, LivaNova, Inc., and 4C Medical Technologies, Inc. are intensively investing in R&D, strategic partnerships, and product portfolio expansion to maintain a competitive edge and meet the evolving demands of cardiac care.

Future Outlook

The pulmonary valve replacement market is poised for steady growth, supported by:

Technological Innovations: Ongoing advancements in minimally invasive procedures and implant materials will continue to improve patient outcomes and safety.

Expanding Clinical Adoption: Rising awareness and early detection efforts will drive greater adoption of pulmonary valve replacement procedures globally.

Market Penetration in Emerging Economies: Increased healthcare spending and improved infrastructure in emerging regions are expected to offer lucrative growth opportunities.

https://www.transparencymarketresearch.com/checkout.php?rep_id=85497<ype=S

FAQs

Q1: What is pulmonary valve replacement?
A: Pulmonary valve replacement is a surgical procedure to replace a damaged or diseased pulmonary valve, restoring normal blood flow from the heart to the lungs.

Q2: What factors are driving market growth?
A: Key drivers include the rising prevalence of pulmonary valve disorders, advancements in cardiac surgery techniques, increased use of minimally invasive procedures, and higher healthcare spending.

Q3: What is the forecast market value by 2031?
A: The market is projected to exceed US$ 1.6 billion by 2031, growing at a CAGR of 4.9% from 2023 to 2031.

Q4: Which valve type dominates the market?
A: The mechanical valve segment dominates due to its high durability and long-term performance.

Q5: Who are the primary end-users of these procedures?
A: Hospitals are the primary end-users, supported by ambulatory surgical centers and other specialized healthcare facilities.

Explore Latest Research Reports by Transparency Market Research:

Cast Saw Devices Market - https://www.transparencymarketresearch.com/cast-saw-devices-market.html

Cosmetic Lasers Market - https://www.transparencymarketresearch.com/cosmetic-lasers-market.html

DNA Test Kits Market - https://www.transparencymarketresearch.com/dna-test-kits-market.html

Microbiology Culture Market - https://www.transparencymarketresearch.com/microbiology-culture-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Valve Replacement Market Revenue to Reach USD 1.6 Billion by 2031, Driven by Technological Advancements and Rising Prevalence of Pulmonary Valve Disorders - Exclusive Report by Transparency Market Research, Inc. here

News-ID: 3945647 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments